Middle East & Africa Bioreactors Market Forecast to 2030
Middle East & Africa Bioreactors Market Forecast to 2030 – Regional Analysis – by Scale (Lab-Scale Production, Pilot-Scale Production, and Full-Scale Production), Application (Microbial Application, Cell Culture Application, and Others), Technology (Fed-Batch Bioreactors and Perfusion Bioreactors), and End User (Biopharma Manufacturers, Research and Development Organizations, and Contract Manufacturing Organization)
$2,840 – $4,440
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Increasing Adoption of Single-Use Bioreactors Bolsters Middle East & Africa Bioreactors Market
Various manufacturers are developing single-use bioreactors (SUBs) as they are robust and provide the high performance required for commercial manufacturing of biopharmaceuticals. Advantages such as film technologies, stirring mechanisms, bioreactor designs, and sensor systems have contributed toward increasing the adoption of disposable reactors from the lab to the production scale. The single-use bioreactors provide next-generation cell and gene therapies and continuous bioprocessing. The advancements in cell-culture processes have developed higher titers and cell densities, which have facilitated the adoption of SUBs.
Single-use bioreactors reduce the risks of contamination and decrease production turnaround times. In the last few years, the use of single-use bioreactors has increased in modern biopharmaceutical processes owing to their unique ability to enhance flexibility, reduce investment, and limit operational costs. Also, many companies have developed single-use bioreactors for producing a wide range of therapeutics. For instance, in March 2021, Thermo Fischer Scientific launched the 3,000 L and 5,000 L HyPerforma DynaDrive single-use bioreactors.
The reduction in validation time has been one of the essential benefits of single-use bioreactors. The rising adoption of single-use bioreactors for upstream bioprocessing is driving the market growth. For instance, Sartorius AG offers a wide range of single-use bioreactors. The company provides ambr 15 for a 10-15 mL micro bioreactor scale and Biostat STR for 50-2000L. The increasing acceptance of single-use bioreactors for the production of therapeutics is driving the market for bioreactors.
Middle East & Africa Bioreactors Market Overview
In Saudi Arabia, the bioreactors market is driven by a rising number of startup companies and increasing awareness about research and developments happening in the country for the enhancement of research activities. Research and technology are significantly governed by an increasing number of research projects undertaken by institutes such as King Abdullah University of Science and Technology. Well-developed research centers focus on increasing research studies for the treatment of various diseases, which in turn would increase the development of new treatment methods and hence also fuel the market growth. For instance, a study, “Chimeric antigen receptor structure and manufacturing of clinical grade CAR engineered cells using different bioreactors,” was conducted in 2022 under the Stem Cell & Tissue Re-engineering Program in King Faisal Specialist Hospital & Research Centre, Kingdom of Saudi Arabia.
In Saudi Arabia, government initiatives are responsible for private sector involvement in healthcare expansion and investment. The developed healthcare expenditure and increasing government initiatives in Saudi Arabia are influencing the growth of the bioreactors market.
Middle East & Africa Bioreactors Market Revenue and Forecast to 2030 (US$ Million)
Middle East & Africa Bioreactors Market Segmentation
The Middle East & Africa bioreactors market is segmented based on scale, application, technology, end user, and country. Based on scale, the Middle East & Africa bioreactors market is segmented into lab-scale production, pilot-scale production, and full-scale production. The pilot-scale production segment held the largest market share in 2022.
In terms of application, the Middle East & Africa bioreactors market is categorized into microbial application, cell culture application, and others. The cell culture application segment held the largest market share in 2022.
By technology, the Middle East & Africa bioreactors market is bifurcated into fed-batch bioreactors and perfusion bioreactors. The fed-batch bioreactors segment held a larger market share in 2022.
Based on end user, the Middle East & Africa bioreactors market is categorized into biopharma manufacturers, research and development organizations, and contract manufacturing organization. The research and development organizations segment held the largest market share in 2022.
Based on country, the Middle East & Africa bioreactors market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa bioreactors market share in 2022.
Applikon Biotechnology BV, General Electric Co, Merck KGaA, Pall Corp, PBS Biotech Inc, Sartorius AG, Solaris Biotechnology SRL, and Thermo Fisher Scientific Inc are some of the leading players operating in the Middle East & Africa bioreactors market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to the Research Team’ research, the Middle East & Africa bioreactors market was valued at US$ 194.58 million in 2022 and is expected to reach US$ 292.40 million by 2030, registering a CAGR of 5.2% from 2022 to 2030. Rapid growth of pharmaceutical and biotechnology industry and increasing adoption of single-use bioreactors are among the critical factors attributed to the Middle East & Africa bioreactors market expansion.
In recent years, the pharmaceutical industry has been growing at an unprecedented pace. Big pharmaceutical companies and contract research organizations (CROs) are coming up with new medicines and therapy forms to treat a wide range of indications. The biopharmaceuticals market is increasing. The strong demand for biologics and biosimilars has driven the growth of the industry. Sanofi, AbbVie, and Virax Biolabs are among the biopharma businesses that are discovering a lot of business potential in the Middle East, specifically in Saudi Arabia and the UAE. These nations have become desirable markets for new therapies due to their expanding populations and rising rates of chronic illnesses, including diabetes and cardiovascular disease. By forming strategic alliances with regional organizations, biopharmas can capitalize on incentives provided by governments keen to host innovation hubs, therefore advancing R&D or marketing existing products. For instance, the UAE has created a number of official free economic zones that provide biotech companies that are willing to conduct business internationally with conducive business conditions. These zones, which include the Abu Dhabi Global Market and the Dubai Biotechnology and Research Park, offer a number of benefits, like as tax breaks, 100% foreign ownership, and streamlined administrative procedures. Factors such as increasing biologics approval, growing biosimilar pipeline, and rising investment in research activities are facilitating the growth of the industry.
The increasing approvals in gene and cell therapies are favoring market growth. The approved gene therapies are Glybera-used to treat Lipoprotein Lipase Deficiency and Strimvelis- treating ADA-Severe Combined Immuno Deficiency. Thus, the factors mentioned above are increasing the demand for the large-scale production of various therapeutics, thereby facilitating the growth of the bioreactors market globally.
On the contrary, stringent regulatory framework hurdles the growth of Middle East & Africa bioreactors market.
Based on scale, the Middle East & Africa bioreactors market is categorized into lab-scale production, pilot-scale production, and full-scale production. The pilot-scale production segment held 48.4% share of Middle East & Africa bioreactors market in 2022, amassing US$ 94.15 million. It is projected to garner US$ 139.59 million by 2030 to expand at 5.0% CAGR during 2022-2030.
In terms of application, the Middle East & Africa bioreactors market is segmented into microbial application, cell culture application, and others. The cell culture application segment held 48.6% share of Middle East & Africa bioreactors market in 2022, amassing US$ 94.55 million. It is projected to garner US$ 140.06 million by 2030 to expand at 5.0% CAGR during 2022-2030.
By technology, the Middle East & Africa bioreactors market is bifurcated into fed-batch bioreactors and perfusion bioreactors. The fed-batch bioreactors segment held 62.2% share of Middle East & Africa bioreactors market in 2022, amassing US$ 121.05 million. It is projected to garner US$ 174.21 million by 2030 to expand at 4.7% CAGR during 2022-2030.
Based on end user, the Middle East & Africa bioreactors market is categorized into biopharma manufacturers, research and development organizations, and contract manufacturing organization. The research and development organizations segment held 60.4% share of Middle East & Africa bioreactors market in 2022, amassing US$ 117.55 million. It is projected to garner US$ 185.88 million by 2030 to expand at 5.9% CAGR during 2022-2030.
Based on country, the Middle East & Africa bioreactors market has been categorized into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Our regional analysis states that Saudi Arabia captured 31.5% share of Middle East & Africa bioreactors market in 2022. It was assessed at US$ 61.31 million in 2022 and is likely to hit US$ 98.07 million by 2030, exhibiting a CAGR of 6.0% during 2022-2030.
Key players operating in the Middle East & Africa bioreactors market are Applikon Biotechnology BV, General Electric Co, Merck KGaA, Pall Corp, PBS Biotech Inc, Sartorius AG, Solaris Biotechnology SRL, and Thermo Fisher Scientific Inc, among others.
In December 2022, Merck KGaA announced the acquisition of Erbi Biosystems, a developer of 2 ml micro-bioreactor platform technology. The acquisition has allowed Merck KGaA to incorporate Erbi Biosystems’s bioreactor, Breez, into its portfolio and strengthen its therapeutic proteins portfolio. After the acquisition, Merck KGaA aims to increase its Group sales to approximately US$ 26.7 billion ( 25 billion) by 2025.
In October 2021, Thermo Fisher Scientific Inc and 3M Separation and Purification Sciences have collaborated on biologics manufacturing. Under the agreement, both companies will incorporate their technologies to produce biologics. The collaboration has enabled their customers to pair the 3M Harvest RC Chromatographic Clarifier, which is a single-stage purification solution, with Thermo Scientific HyPerforma Single-Use Bioreactor Systems. The integration of two technologies will provide great efficiency and scalability in the therapeutic manufacturing process.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa bioreactors market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the Middle East & Africa bioreactors market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
TABLE OF CONTENTS
1. Introduction
1.1 the Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Bioreactors Market – Key Industry Dynamics
4.1 Bioreactors Market – Key Industry Dynamics
4.2 Market Drivers
4.2.1 Increasing Adoption of Single-Use Bioreactors
4.2.2 Rapid Growth of Pharmaceutical and Biotechnology Industry
4.3 Market Restraints
4.3.1 Stringent Regulatory Framework
4.4 Market Opportunities
4.4.1 Rising Demand for Personalized Medicine
4.5 Future Trends
4.5.1 Technological Advancements in Bioreactors
4.6 Impact of Drivers and Restraints:
5. Bioreactors Market – Middle East & Africa Market Analysis
5.1 Overview
5.2 Bioreactors Market Revenue (US$ Million), 2020 – 2030
6. Middle East & Africa Bioreactors Market Analysis – Scale
6.1 Overview
6.2 Bioreactors Market Revenue Share, by Scale 2022 & 2030 (%)
6.3 Lab-Scale Production
6.3.1 Overview
6.3.2 Lab-Scale Production Market, Revenue and Forecast to 2030 (US$ Million)
6.4 Pilot-Scale Production
6.4.1 Overview
6.4.2 Pilot-Scale Production Market, Revenue and Forecast to 2030 (US$ Million)
6.5 Full-Scale Production
6.5.1 Overview
6.5.2 Full-Scale Production Market, Revenue and Forecast to 2030 (US$ Million)
7. Middle East & Africa Bioreactors Market Analysis – Application
7.1 Overview
7.2 Bioreactors Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Microbial Application
7.3.1 Overview
7.3.2 Microbial Application Market, Revenue and Forecast to 2030 (US$ Million)
7.4 Cell Culture Application
7.4.1 Overview
7.4.2 Cell Culture Application Market, Revenue and Forecast to 2030 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others Market, Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa Bioreactors Market Analysis – Technology
8.1 Overview
8.2 Bioreactors Market Revenue Share, by Technology 2022 & 2030 (%)
8.3 Fed-Batch Bioreactors
8.3.1 Overview
8.3.2 Fed-Batch Bioreactors Market, Revenue and Forecast to 2030 (US$ Million)
8.4 Perfusion Bioreactors
8.4.1 Overview
8.4.2 Perfusion Bioreactors Market, Revenue and Forecast to 2030 (US$ Million)
9. Middle East & Africa Bioreactors Market Analysis – End User
9.1 Overview
9.2 Bioreactors Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Biopharma Manufacturers
9.3.1 Overview
9.3.2 Biopharma Manufacturers Market, Revenue and Forecast to 2030 (US$ Million)
9.4 Research and Development Organizations
9.4.1 Overview
9.4.2 Research and Development Organizations Market, Revenue and Forecast to 2030 (US$ Million)
9.5 Contract Manufacturing Organization
9.5.1 Overview
9.5.2 Contract Manufacturing Organization Market, Revenue and Forecast to 2030 (US$ Million)
10. Middle East & Africa Bioreactors Market – by Country Analysis
10.1 Middle East & Africa Bioreactors Market
10.1.1 Middle East & Africa Bioreactors Market Revenue and Forecasts and Analysis – By Country
10.1.1.1 Saudi Arabia
10.1.1.2 Overview
10.1.1.3 Saudi Arabia: Bioreactors Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.4 Saudi Arabia Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn)
10.1.1.4.1 Saudi Arabia Bioreactors Market Breakdown by Scale
10.1.1.4.2 Saudi Arabia Bioreactors Market Breakdown by Application
10.1.1.4.3 Saudi Arabia Bioreactors Market Breakdown by Technology
10.1.1.4.4 Saudi Arabia Bioreactors Market Breakdown by End User
10.1.1.5 South Africa
10.1.1.6 Overview
10.1.1.7 South Africa: Bioreactors Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.7.1 South Africa Bioreactors Market Breakdown by Scale
10.1.1.7.2 South Africa Bioreactors Market Breakdown by Application
10.1.1.7.3 South Africa Bioreactors Market Breakdown by Technology
10.1.1.7.4 South Africa Bioreactors Market Breakdown by End User
10.1.1.8 UAE
10.1.1.9 Overview
10.1.1.10 United Arab Emirates: Bioreactors Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.10.1 United Arab Emirates Bioreactors Market Breakdown by Scale
10.1.1.10.2 United Arab Emirates Bioreactors Market Breakdown by Application
10.1.1.10.3 United Arab Emirates Bioreactors Market Breakdown by Technology
10.1.1.10.4 United Arab Emirates Bioreactors Market Breakdown by End User
10.1.1.11 Rest of Middle East & Africa
10.1.1.12 Overview
10.1.1.13 Rest of Middle East & Africa: Bioreactors Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.13.1 Rest of Middle East & Africa Bioreactors Market Breakdown by Scale
10.1.1.13.2 Rest of Middle East & Africa Bioreactors Market Breakdown by Application
10.1.1.13.3 Rest of Middle East & Africa Bioreactors Market Breakdown by Technology
10.1.1.13.4 Rest of Middle East & Africa Bioreactors Market Breakdown by End User
11. Bioreactors Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Bioreactors Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 PBS Biotech Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 General Electric Co
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Merck KGaA
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Thermo Fisher Scientific Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Sartorius AG
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Pall Corp
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Solaris Biotechnology SRL
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. Appendix
13.1 About the Research Team
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Bioreactors Market Segmentation
Table 2. Saudi Arabia Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) – By Scale
Table 3. Saudi Arabia Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) – By Application
Table 4. Saudi Arabia Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) – By Technology
Table 5. Saudi Arabia Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) – By End User
Table 6. South Africa Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) – By Scale
Table 7. South Africa Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) – By Application
Table 8. South Africa Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) – By Technology
Table 9. South Africa Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) – By End User
Table 10. United Arab Emirates Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) – By Scale
Table 11. United Arab Emirates Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) – By Application
Table 12. United Arab Emirates Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) – By Technology
Table 13. United Arab Emirates Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) – By End User
Table 14. Rest of Middle East & Africa Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) – By Scale
Table 15. Rest of Middle East & Africa Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) – By Application
Table 16. Rest of Middle East & Africa Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) – By Technology
Table 17. Rest of Middle East & Africa Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) – By End User
Table 18. Recent Inorganic Growth Strategies in the Bioreactors Market
Table 19. Recent Organic Growth Strategies in the Bioreactors Market
Table 20. Glossary of Terms, Bioreactors Market
LIST OF FIGURES
Figure 1. Bioreactors Market Segmentation, By Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. Bioreactors Market Revenue (US$ Million), 2020 – 2030
Figure 4. Bioreactors Market Revenue Share, by Scale 2022 & 2030 (%)
Figure 5. Lab-Scale Production Market Revenue and Forecasts to 2030 (US$ Million)
Figure 6. Pilot-Scale Production Market Revenue and Forecasts to 2030 (US$ Million)
Figure 7. Full-Scale Production Market Revenue and Forecasts to 2030 (US$ Million)
Figure 8. Bioreactors Market Revenue Share, by Application 2022 & 2030 (%)
Figure 9. Microbial Application Market Revenue and Forecasts to 2030 (US$ Million)
Figure 10. Cell Culture Application Market Revenue and Forecasts to 2030 (US$ Million)
Figure 11. Others Market Revenue and Forecasts to 2030 (US$ Million)
Figure 12. Bioreactors Market Revenue Share, by Technology 2022 & 2030 (%)
Figure 13. Fed-Batch Bioreactors Market Revenue and Forecasts to 2030 (US$ Million)
Figure 14. Perfusion Bioreactors Market Revenue and Forecasts to 2030 (US$ Million)
Figure 15. Bioreactors Market Revenue Share, by End User 2022 & 2030 (%)
Figure 16. Biopharma Manufacturers Market Revenue and Forecasts to 2030 (US$ Million)
Figure 17. Research and Development Organizations Market Revenue and Forecasts to 2030 (US$ Million)
Figure 18. Contract Manufacturing Organization Market Revenue and Forecasts to 2030 (US$ Million)
Figure 19. Middle East & Africa: Bioreactors Market, by Key Country – Revenue (2022) (US$ Million)
Figure 20. Middle East & Africa Bioreactors Market Breakdown by Key Countries, 2022 and 2030 (%)
Figure 21. Saudi Arabia Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 22. South Africa Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 23. United Arab Emirates Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 24. Rest of Middle East & Africa Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 25. Growth Strategies in the Bioreactors Market
The List of Companies – Middle East & Africa Bioreactors Market
1. General Electric Co
2. Merck KGaA
3. Pall Corp
4. PBS Biotech Inc
5. Sartorius AG
6. Solaris Biotechnology SRL
7. Thermo Fisher Scientific Inc
You must be logged in to post a review.
Reviews
There are no reviews yet.